. Author manuscript; available in PMC: 2020 Jan 1.

Published in final edited form as: J Ultrasound Med. 2018 May 15;38(1):103–111. doi: 10.1002/jum.14668

Table 7.

Comparison Between our Initial Data Set and This New Cohort of Patients With ALD

Parameter	Initial Data Set	ALD	PBC	AIH
Patients	136	51	24	20
Cutoff for METAVIR F≥2 fibrosis, kPa	7.29	7.29	7.29	7.29
Sensitivity (95% CI), %	91.4 (75.6–97.8) (32/35)	88.9 (67.2–96.9) (16/18)	87.5 (52.9–97.8) (7/8)	85.7 (48.7–97.4) (6/7)
Specificity (95% CI), %	52.5 (42.3–62.4) (53/101)	39.4 (24.7–56.3) (13/33)	43.8 (23.1–66.8) (7/16)	38.5 (17.7–64.5) (5/13)
PPV (95% CI), %	40.0 (29.4–51.6) (32/80)	44.4 (29.5–60.4) (16/36)	43.8 (23.1–66.8) (7/16)	42.9 (21.4–67.4) (6/14)
NPV (95% CI), %	94.6 (84.2–98.6) (53/56)	86.7 (62.1–96.3) (13/15)	87.5 (52.9–97.8) (7/8)	83.3 (43.6–97.0) (5/6)
Positive LR (95% CI)	1.92 (1.53–2.41)	1.47 (1.07–2.02)	1.56 (0.94–2.58)	1.39 (0.82–2.36)
Negative LR (95% CI)	0.16 (0.05–0.49)	0.28 (0.07–1.11)	0.29 (0.04–1.94)	0.37 (0.05–2.59)